[Proteomic analysis of prostate cancer using surface enhanced laser desorption/ionization mass spectrometry]
- PMID: 16405834
[Proteomic analysis of prostate cancer using surface enhanced laser desorption/ionization mass spectrometry]
Abstract
Objective: To identify the serum biomarkers of prostate cancer by using protein chip and bioinformatics.
Methods: Eighty three prostate cancer (PCA) patients and ninety five healthy people from mass screen in Changchun were detected by surface-enhanced laser desorption/ionization mass spectrometry (SELDI-MS). The data of spectra were analyzed by bioinformatics tools-Biomarker Wizard and Biomarker Pattern.
Results: Compared with the spectra of healthy people, there were 18 potential markers detected in the spectra of the PCA patients, the protein expression was high in 4 of which and low in the 10 of which. The softwares Biomarkerwizard and Biomarker Pattern automatically, under given conditions, selected 8 biomarker proteins to be used to establish a five layer decision tree differentiate to diagnose PCA and differentiate PCA from healthy people with a specificity of 92.632% and a sensitivity of 96.386%.
Conclusion: New serum biomarkers of PCA have been identified, and this SELDI mass spectrometry coupled with decision tree classification algorithm will provide a highly accurate and innovative approach for the early diagnosis of PCA.
Similar articles
-
Application of surface-enhanced laser desorption/ionization time-of-flight-based serum proteomic array technique for the early diagnosis of prostate cancer.Asian J Androl. 2006 Jan;8(1):45-51. doi: 10.1111/j.1745-7262.2006.00103.x. Asian J Androl. 2006. PMID: 16372118
-
A serum proteomic pattern for the detection of colorectal adenocarcinoma using surface enhanced laser desorption and ionization mass spectrometry.Cancer Invest. 2006 Dec;24(8):747-53. doi: 10.1080/07357900601063873. Cancer Invest. 2006. PMID: 17162557
-
Identification of lung cancer patients by serum protein profiling using surface-enhanced laser desorption/ionization time-of-flight mass spectrometry.Am J Clin Oncol. 2008 Apr;31(2):133-9. doi: 10.1097/COC.0b013e318145b98b. Am J Clin Oncol. 2008. PMID: 18391596
-
[Proteomic profiling: the potential of Seldi-Tof for the identification of new cancer biomarkers].Bull Cancer. 2005 Sep;92(9):763-8. Bull Cancer. 2005. PMID: 16203265 Review. French.
-
Proteomic patterns: their potential for disease diagnosis.Mol Cell Endocrinol. 2005 Jan 31;230(1-2):95-106. doi: 10.1016/j.mce.2004.10.010. Mol Cell Endocrinol. 2005. PMID: 15664456 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical